{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:19:02Z","timestamp":1778775542863,"version":"3.51.4"},"reference-count":110,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2010,2,7]],"date-time":"2010-02-07T00:00:00Z","timestamp":1265500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,2,7]],"date-time":"2010-02-07T00:00:00Z","timestamp":1265500800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00005-010-0068-z","type":"journal-article","created":{"date-parts":[[2010,2,6]],"date-time":"2010-02-06T14:41:36Z","timestamp":1265467296000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunoprophylaxis of Tuberculosis: An Update of Emerging Trends"],"prefix":"10.2478","volume":"58","author":[{"given":"Neelja","family":"Singhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beenu","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2010,2,7]]},"reference":[{"key":"68_CR1","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/IAI.65.5.1856-1862.1997","volume":"65","author":"C Abou-Zeid","year":"1997","unstructured":"Abou-Zeid C, Gares MP, Inwald J et al (1997) Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect Immun 65:1856\u20131862","journal-title":"Infect Immun"},{"key":"68_CR2","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.vaccine.2006.03.072","volume":"24","author":"EM Agger","year":"2006","unstructured":"Agger EM, Rosenkrands I, Olsen AW et al (2006) Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31. Vaccine 24:5452\u20135460","journal-title":"Vaccine"},{"key":"68_CR3","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.vaccine.2005.11.051","volume":"24","author":"LD Aguilar","year":"2006","unstructured":"Aguilar LD, Infante E, Bianco MV et al (2006) Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a BALB\/c mouse model of progressive pulmonary tuberculosis. Vaccine 24:2333\u20132342","journal-title":"Vaccine"},{"key":"68_CR4","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1128\/IAI.01611-06","volume":"75","author":"AM Aguirre-Blanco","year":"2007","unstructured":"Aguirre-Blanco AM, Lukey PT, Cliff JM et al (2007) Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro. Infect Immun 75:3197\u20133201","journal-title":"Infect Immun"},{"key":"68_CR5","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","volume":"291","author":"NE Aronson","year":"2004","unstructured":"Aronson NE, Santosham M, Comstock GW et al (2004) Long term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60\u00a0year follow-up study. JAMA 291:2086\u20132091","journal-title":"JAMA"},{"key":"68_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pep.2007.11.016","volume":"59","author":"Y Bai","year":"2008","unstructured":"Bai Y, Xue Y, Gao H et al (2008) Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model. Protein Expr Purif 59:189\u2013196","journal-title":"Protein Expr Purif"},{"key":"68_CR7","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","volume":"66","author":"SL Baldwin","year":"1998","unstructured":"Baldwin SL, D\u2019Souza C, Roberts AD et al (1998) Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun 66:2951\u20132959","journal-title":"Infect Immun"},{"key":"68_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","volume":"2","author":"M Behr","year":"2002","unstructured":"Behr M (2002) BCG\u2013\u2013different strains, different vaccines? Lancet Infect Dis 2:86\u201392","journal-title":"Lancet Infect Dis"},{"key":"68_CR9","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","volume":"181","author":"S Bertholet","year":"2008","unstructured":"Bertholet S, Ireton GC, Kahn M et al (2008) Identification of human T-cell antigens for the development of vaccines against Mycobacterium tuberculosis. J Immunol 181:7948\u20137957","journal-title":"J Immunol"},{"key":"68_CR10","doi-asserted-by":"crossref","DOI":"10.1128\/9781555818357","volume-title":"Tuberculosis:pathogenesis, protection and control","author":"BR Bloom","year":"1994","unstructured":"Bloom BR, Fine PEM (1994) The BCG experience: implications for future vaccine against tuberculosis. In: Bloom BR (ed) Tuberculosis:pathogenesis, protection and control. American society for Microbiology Press, Washington DC"},{"key":"68_CR11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/IAI.68.2.791-795.2000","volume":"68","author":"L Brandt","year":"2000","unstructured":"Brandt L, Elhay M, Rosenkrands I et al (2000) ESAT-6 subunit vaccination Mycobacterium tuberculosis. Infect Immun 68:791\u2013795","journal-title":"Infect Immun"},{"key":"68_CR12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","volume":"70","author":"L Brandt","year":"2002","unstructured":"Brandt L, Cunha JF, Weinrich OA et al (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70:672\u2013678","journal-title":"Infect Immun"},{"key":"68_CR13","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1128\/IAI.72.11.6622-6632.2004","volume":"72","author":"L Brandt","year":"2004","unstructured":"Brandt L, Skeiky YA, Alderson MR et al (2004) The protective effect of Mycobacterium bovis BCG vaccine is increased by co-administration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in Mycobacterium tuberculosis-infected guinea pigs. Infect Immun 72:6622\u20136632","journal-title":"Infect Immun"},{"issue":"suppl 3","key":"68_CR14","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","volume":"31","author":"TF Brewer","year":"2000","unstructured":"Brewer TF (2000) Preventing tuberculosis with Bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 31(suppl 3):S64\u2013S67","journal-title":"Clin Infect Dis"},{"key":"68_CR15","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","volume":"104","author":"R Brosch","year":"2007","unstructured":"Brosch R, Gordon SV, Garnier T et al (2007) Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA 104:5596\u20135601","journal-title":"Proc Natl Acad Sci USA"},{"key":"68_CR16","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/j.vaccine.2008.02.023","volume":"26","author":"P Brun","year":"2008","unstructured":"Brun P, Zumbo A, Castagliuolo I et al (2008) Intranasal delivery of DNA encoding antigens of Mycobacetrium tuberculosis by non-pathogenic invasive Escherichia coli. Vaccine 26:1934\u20131941","journal-title":"Vaccine"},{"key":"68_CR17","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1016\/j.vaccine.2005.03.024","volume":"23","author":"H Cai","year":"2005","unstructured":"Cai H, Hu XD, Yu DH et al (2005) Combined DNA vaccine encapsulated in microspheres enhanced protection efficacy against Mycobacterium tuberculosis infection of mice. Vaccine 23:4167\u20134174","journal-title":"Vaccine"},{"key":"68_CR18","first-page":"567","volume":"19","author":"A Calmette","year":"1929","unstructured":"Calmette A, Plotz H (1929) Protective inoculation against tuberculosis with BCG. Am Rev Tuberc 19:567\u2013572","journal-title":"Am Rev Tuberc"},{"key":"68_CR19","first-page":"561","volume":"35","author":"A Calmette","year":"1921","unstructured":"Calmette A, Bouquet A, Negre L et al (1921) Contributiona l\u2032etude du bacilli tuberculeux bilie. Ann Inst Pasteur 35:561\u2013570","journal-title":"Ann Inst Pasteur"},{"key":"68_CR20","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/IAI.74.3.1718-1724.2006","volume":"74","author":"AI Castillo-Rodal","year":"2006","unstructured":"Castillo-Rodal AI, Castanon-Arreola M, Hernandez-Pando R et al (2006) Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB\/c model of progressive pulmonary tuberculosis. Infect Immun 74:1718\u20131724","journal-title":"Infect Immun"},{"key":"68_CR21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.vaccine.2005.08.041","volume":"24","author":"I Cebere","year":"2006","unstructured":"Cebere I, Dorrell L, McShane H et al (2006) Phase I clinical trial safety of DNA-and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers. Vaccine 24:417\u2013425","journal-title":"Vaccine"},{"key":"68_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/dna.2007.0648","volume":"27","author":"S Chang-hong","year":"2008","unstructured":"Chang-hong S, Xiao-wu W, Hai Z et al (2008) Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis. DNA Cell Biol 27:199\u2013207","journal-title":"DNA Cell Biol"},{"key":"68_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-0556-4-1","volume":"4","author":"AA Coelho-Castelo","year":"2006","unstructured":"Coelho-Castelo AA, Trombone AP, Rosada RS et al (2006) Tissue distribution of a plasmid DNA encoding HSP65 gene is dependent on the dose administered through intramuscular delivery. Genet Vaccines Ther 4:1","journal-title":"Genet Vaccines Ther"},{"key":"68_CR24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz GA, Brewer TF, Berkey CS et al (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta analysis of the published literature. JAMA 271:698\u2013702","journal-title":"JAMA"},{"key":"68_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0041-3879(85)90064-9","volume":"66","author":"FM Collins","year":"1985","unstructured":"Collins FM (1985) Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence. Tubercle 66:267\u2013276","journal-title":"Tubercle"},{"key":"68_CR26","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/IAI.70.7.3681-3688.2002","volume":"70","author":"S D\u2019Souza","year":"2002","unstructured":"D\u2019Souza S, Rosseels V, Denis O et al (2002) Improved tuberculosis DNA vaccines by formulation in cationic lipids. Infect Immun 70:3681\u20133688","journal-title":"Infect Immun"},{"key":"68_CR27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/499825","volume":"193","author":"V Davids","year":"2006","unstructured":"Davids V, Hanekom WA, Mansoor N et al (2006) The effect of bacille Calmette-Guerin vaccine strain and route of administration on induced immune responses in vaccinated infants. J Infect Dis 193:531\u2013536","journal-title":"J Infect Dis"},{"key":"68_CR28","doi-asserted-by":"crossref","unstructured":"De Bruyn G, Garner P (2003) Mycobacterium vaccae immunotherapy for treating tuberculosis. Cochrane Database Syst Rev: CD001166s","DOI":"10.1002\/14651858.CD001166"},{"key":"68_CR29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cellimm.2003.09.003","volume":"225","author":"KS Denis-Mize","year":"2003","unstructured":"Denis-Mize KS, Dupuis M, Singh M et al (2003) Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles. Cell Immunol 225:12\u201320","journal-title":"Cell Immunol"},{"key":"68_CR30","doi-asserted-by":"crossref","first-page":"6332","DOI":"10.4049\/jimmunol.174.10.6332","volume":"174","author":"J Dietrich","year":"2005","unstructured":"Dietrich J, Aagaard C, Leah R et al (2005) Exchanging ESAT-6 with TB10.4 in a Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy. J Immunol 174:6332\u20136339","journal-title":"J Immunol"},{"key":"68_CR31","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","volume":"177","author":"J Dietrich","year":"2006","unstructured":"Dietrich J, Andersen C, Rappuoli R et al (2006) Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior Bacillus Calmette Guerin imunity. J Immunol 177:6353\u20136360","journal-title":"J Immunol"},{"key":"68_CR32","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/CMR.18.4.687-702.2005","volume":"18","author":"TM Doherty","year":"2005","unstructured":"Doherty TM, Andersen P (2005) Vaccines for tuberculosis: novel concepts and recent progress. Clin Microbiol Rev 18:687\u2013702","journal-title":"Clin Microbiol Rev"},{"key":"68_CR33","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1086\/425931","volume":"190","author":"TM Doherty","year":"2004","unstructured":"Doherty TM, Olsen AW, Weischenfeldt J et al (2004) Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis. J Infect Dis 190:2146\u20132152","journal-title":"J Infect Dis"},{"key":"68_CR34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/08820130701690741","volume":"37","author":"J Dou","year":"2008","unstructured":"Dou J, Tang Q, Zhao F et al (2008) Comparison of immune responses induced in mice by vaccination with DNA vaccine constructs expressing mycobacterial antigen 85A and interleukin -21 and bacillus Calmette-Guerin. Immunol Invest 37:113\u2013127","journal-title":"Immunol Invest"},{"key":"68_CR35","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1128\/IAI.72.12.6945-6950.2004","volume":"72","author":"JC Ferraz","year":"2004","unstructured":"Ferraz JC, Stavropoulos E, Yang M et al (2004) A heterologous DNA priming- Mycobacterium bovis BCG boosting immunization strategy using mycobacterial HSP70, HSP65 and Apa antigens improves protection against tuberculosis in mice. Infect Immun 72:6945\u20136950","journal-title":"Infect Immun"},{"key":"68_CR36","volume-title":"Issues relating to the use of BCG in immunization programmes. A discussion document","author":"PEM Fine","year":"1999","unstructured":"Fine PEM, Carneiro IAM, Milstien JB et al (1999) Issues relating to the use of BCG in immunization programmes. A discussion document. World Health Organization, Geneva"},{"key":"68_CR37","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1128\/IAI.69.8.4839-4845.2001","volume":"69","author":"DP Fonseca","year":"2001","unstructured":"Fonseca DP, Benaissa-Trouw B, van Engelen MV et al (2001) Induction of cell mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kDa protein. Infect Immun 69:4839\u20134845","journal-title":"Infect Immun"},{"key":"68_CR38","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1016\/j.vaccine.2006.04.037","volume":"24","author":"P Gorak-Stolinska","year":"2006","unstructured":"Gorak-Stolinska P, Weir RE, Floyd S et al (2006) Immunogenicity of Danish-SSI 1331 BCG vaccine in the UK: comparison with Glaxo-Evans 1077 BCG vaccine. Vaccine 24:5726\u20135733","journal-title":"Vaccine"},{"key":"68_CR39","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1016\/j.vaccine.2007.01.120","volume":"25","author":"JR Greenland","year":"2007","unstructured":"Greenland JR, Letvin NL (2007) Chemical adjuvants for plasmid DNA vaccines. Vaccine 25:3731\u20133737","journal-title":"Vaccine"},{"key":"68_CR40","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","volume":"115","author":"L Grode","year":"2005","unstructured":"Grode L, Seiler P, Baumann S et al (2005) Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacilli Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 115:2472\u20132479","journal-title":"J Clin Invest"},{"key":"68_CR41","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/IAI.00526-08","volume":"77","author":"A Gupta","year":"2009","unstructured":"Gupta A, Geetha N, Mani J et al (2009) Immunogenicity and protective efficacy of Mycobacterium w against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M.w by the aerosol or parenteral route. Infect Immun 77:223\u2013231","journal-title":"Infect Immun"},{"key":"68_CR42","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.1016\/j.vaccine.2007.07.042","volume":"25","author":"M Henao-Tamayo","year":"2007","unstructured":"Henao-Tamayo M, Junqueira-Kipnis AP, Ordway D et al (2007) A mutant of Mycobacterium tuberculosis lacking the 19-kDA lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties. Vaccine 25:7153\u20137159","journal-title":"Vaccine"},{"key":"68_CR43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tube.2006.01.022","volume":"86","author":"R Hernandez Pando","year":"2006","unstructured":"Hernandez Pando R, Aguilar LD, Infante E et al (2006) The use of mutant bacteria as new vaccines to prevent tuberculosis. Tuberculosis 86:203\u2013210","journal-title":"Tuberculosis"},{"key":"68_CR44","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1073\/pnas.95.9.5299","volume":"95","author":"J Hess","year":"1998","unstructured":"Hess J, Miko D, Catic A et al (1998) Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc Natl Acad Sci USA 95:5299\u20135304","journal-title":"Proc Natl Acad Sci USA"},{"key":"68_CR45","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.68.5.2888-2898.2000","volume":"68","author":"MK Hondalus","year":"2000","unstructured":"Hondalus MK, Bardarov S, Russell R et al (2000) Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun 68:2888\u20132898","journal-title":"Infect Immun"},{"key":"68_CR46","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","volume":"71","author":"MA Horwitz","year":"2003","unstructured":"Horwitz MA, Harth G (2003) A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 71:1672\u20131679","journal-title":"Infect Immun"},{"key":"68_CR47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2567.2002.01366.x","volume":"105","author":"GD Hussey","year":"2002","unstructured":"Hussey GD, Watkins ML, Goddard EA et al (2002) Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology 105:314\u2013324","journal-title":"Immunology"},{"key":"68_CR48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2249.2005.02832.x","volume":"141","author":"E Infante","year":"2005","unstructured":"Infante E, Aguilar LD, Gicquel B et al (2005) Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant. Clin Exp Immunol 141:21\u201328","journal-title":"Clin Exp Immunol"},{"key":"68_CR49","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.4049\/jimmunol.158.10.4591","volume":"158","author":"A Iwasaki","year":"1997","unstructured":"Iwasaki A, Stiernholm BJ, Chan AK et al (1997) Enhanced CTL response mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 158:4591\u20134601","journal-title":"J Immunol"},{"key":"68_CR50","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1128\/IAI.67.6.2867-2873.1999","volume":"67","author":"M Jackson","year":"1999","unstructured":"Jackson M, Phalen SW, Lagranderie M et al (1999) Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun 67:2867\u20132873","journal-title":"Infect Immun"},{"key":"68_CR51","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/14760584.5.6.803","volume":"5","author":"W Jechlinger","year":"2006","unstructured":"Jechlinger W (2006) Optimization and delivery of plasmid DNA for vaccination. Expert Rev Vaccines 5:803\u2013825","journal-title":"Expert Rev Vaccines"},{"key":"68_CR52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0165-2478(03)00176-7","volume":"90","author":"P Johansen","year":"2003","unstructured":"Johansen P, Raynaud C, Yang M et al (2003) Anti-mycobacterial immunity induced by a single injection of M. leprae Hsp65-encoding plasmid DNA in biodegradable microparticles. Immunol Lett 90:81\u201385","journal-title":"Immunol Lett"},{"key":"68_CR53","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1128\/IAI.67.4.1702-1707.1999","volume":"67","author":"AT Kamath","year":"1999","unstructured":"Kamath AT, Feng CG, Macdonald M et al (1999) Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 67:1702\u20131707","journal-title":"Infect Immun"},{"key":"68_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.64.1.1-9.1996","volume":"64","author":"MR Lagranderie","year":"1996","unstructured":"Lagranderie MR, Balazuc AM, Deriaud E et al (1996) Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 64:1\u20139","journal-title":"Infect Immun"},{"key":"68_CR55","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","volume":"23","author":"JA Langermans","year":"2005","unstructured":"Langermans JA, Doherty TM, Vervenne RA et al (2005) Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen Ag85B and ESAT-6. Vaccine 23:2740\u20132750","journal-title":"Vaccine"},{"key":"68_CR56","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.1128\/IAI.00531-06","volume":"74","author":"S Lee","year":"2006","unstructured":"Lee S, Jeon BY, Bardarov S et al (2006) Protection elicited by two glutamine auxotrophs of Mycobacterium tuberculosis and in vivo growth phenotypes of the four unique glutamine synthetase mutants in a murine model. Infect Immun 74:6491\u20136495","journal-title":"Infect Immun"},{"key":"68_CR57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1471-2164-9-413","volume":"9","author":"AS Leung","year":"2008","unstructured":"Leung AS, Tran V, Wu Z et al (2008) Novel genome polymorphisms in BCG vaccine strains and impact on efficacy. BMC Genomics 9:413","journal-title":"BMC Genomics"},{"key":"68_CR58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4161\/hv.5.2.7210","volume":"5","author":"J Liu","year":"2009","unstructured":"Liu J, Tran V, Leung AS et al (2009) BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin 5:70\u201378","journal-title":"Hum Vaccin"},{"key":"68_CR59","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0264-410X(96)00274-5","volume":"15","author":"E Lozes","year":"1997","unstructured":"Lozes E, Huygen K, Content J et al (1997) Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding components of the secreted antigen 85 complex. Vaccine 15:830\u2013833","journal-title":"Vaccine"},{"key":"68_CR60","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","volume":"24","author":"C Martin","year":"2006","unstructured":"Martin C, Williams A, Hernandez-Pando R et al (2006) The live Mycobacterium tuberculosis phoP mutant strains is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs. Vaccine 24:3408\u20133419","journal-title":"Vaccine"},{"key":"68_CR61","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","volume":"10","author":"H McShane","year":"2004","unstructured":"McShane H, Pathan AA, Sander CR et al (2004) Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 10:1240\u20131244","journal-title":"Nat Med"},{"key":"68_CR62","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/378515","volume":"188","author":"VS Moorthy","year":"2003","unstructured":"Moorthy VS, Pinder M, Reece WH et al (2003) Safety and immunogenicity of DNA\/modified vaccinia virus ankara malaria vaccination in African adults. J Infect Dis 188:1239\u20131244","journal-title":"J Infect Dis"},{"key":"68_CR63","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1073\/pnas.93.2.934","volume":"93","author":"PJ Murray","year":"1996","unstructured":"Murray PJ, Aldovini A, Young RA (1996) Manipulation and potentiation of antimycobacterial immunity using recombinant bacillus Calmette-Guerin strains that secrete cytokines. Proc Natl Acad Sci USA 93:934\u2013939","journal-title":"Proc Natl Acad Sci USA"},{"key":"68_CR64","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1128\/IAI.68.7.3933-3940.2000","volume":"68","author":"AS Mustafa","year":"2000","unstructured":"Mustafa AS, Shaban FA, Abal AT et al (2000) Identification and HLA restriction of naturally derived Th-1 cell epitopes from the secreted Mycobacterium tuberculosis antigen 85 recognized by antigen-specific human CD4(+) T-cell lines. Infect Immun 68:3933\u20133940","journal-title":"Infect Immun"},{"key":"68_CR65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1515\/BC.2008.063","volume":"389","author":"O Nosareva","year":"2008","unstructured":"Nosareva O, Nesterov A, Boldyrev A et al (2008) Construction of an encapsulated ESAT-6 based anti-TB vaccine and evaluation of its immunogenic properties. Biol Chem 389:579\u2013583","journal-title":"Biol Chem"},{"key":"68_CR66","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1016\/j.vaccine.2009.01.064","volume":"27","author":"M Okada","year":"2009","unstructured":"Okada M, Kita Y, Nakajima T et al (2009) Novel prophylactic and therapeutic vaccine against tuberculosis. Vaccine 27:3267\u20133270","journal-title":"Vaccine"},{"key":"68_CR67","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/IAI.72.10.6148-6150.2004","volume":"72","author":"WA Olsen","year":"2004","unstructured":"Olsen WA, Williams A, Okkels LM et al (2004) Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 72:6148\u20136150","journal-title":"Infect Immun"},{"key":"68_CR68","first-page":"95","volume":"1","author":"IM Orme","year":"1997","unstructured":"Orme IM (1997) Progress in the development of new vaccines against tuberculosis. Int J Tuberc Lung Dis 1:95\u2013100","journal-title":"Int J Tuberc Lung Dis"},{"key":"68_CR69","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1128\/IAI.71.7.4190-4192.2003","volume":"71","author":"MS Pavelka Jr","year":"2003","unstructured":"Pavelka MS Jr, Chen B, Kelley CL et al (2003) Vaccine efficacy of a lysine auxotroph of Mycobacterium tuberculosis. Infect Immun 71:4190\u20134192","journal-title":"Infect Immun"},{"key":"68_CR70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2958.2001.02500.x","volume":"41","author":"E Perez","year":"2001","unstructured":"Perez E, Samper S, Bordas Y et al (2001) An essential role for phoP in Mycobacterium tuberculosis virulence. Mol Microbiol 41:179\u2013187","journal-title":"Mol Microbiol"},{"key":"68_CR71","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.micinf.2005.03.011","volume":"7","author":"S Reed","year":"2005","unstructured":"Reed S, Lobet Y (2005) Tuberculosis vaccine development: from mouse to man. Microbes Infect 7:922\u2013931","journal-title":"Microbes Infect"},{"key":"68_CR72","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","volume":"32","author":"N Ritz","year":"2008","unstructured":"Ritz N, Hanekom WA, Robins-Browne R et al (2008) Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol Rev 32:821\u2013841","journal-title":"FEMS Microbiol Rev"},{"key":"68_CR73","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1016\/j.vaccine.2008.09.025","volume":"26","author":"M Romano","year":"2008","unstructured":"Romano M, Rindi L, Korf H et al (2008) Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c). Vaccine 26:6053\u20136063","journal-title":"Vaccine"},{"key":"68_CR74","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2005.03.040","volume":"23","author":"SB Sable","year":"2005","unstructured":"Sable SB, Verma I, Khuller GK (2005) Multicomponent antituberculous subunit vaccine based on immunodominant antigens of Mycobacterium tuberculosis. Vaccine 23:4175\u20134184","journal-title":"Vaccine"},{"key":"68_CR75","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.micinf.2005.03.015","volume":"7","author":"JC Sadoff","year":"2005","unstructured":"Sadoff JC, Hone D (2005) The role of \u201cgo no-go decisions\u201d in TB vaccine development. Microbes Infect 7:899\u2013904","journal-title":"Microbes Infect"},{"key":"68_CR76","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.micinf.2005.04.001","volume":"7","author":"VK Sambandamurthy","year":"2005","unstructured":"Sambandamurthy VK, Jacobs WR Jr (2005) Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis. Microbes Infect 7:955\u2013961","journal-title":"Microbes Infect"},{"key":"68_CR77","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nm765","volume":"8","author":"VK Sambandamurthy","year":"2002","unstructured":"Sambandamurthy VK, Wang X, Chen B et al (2002) A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med 8:1171\u20131174","journal-title":"Nat Med"},{"key":"68_CR78","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.73.2.1196-1203.2005","volume":"73","author":"VK Sambandamurthy","year":"2005","unstructured":"Sambandamurthy VK, Derrick SC, Jalapathy KV et al (2005) Long term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis. Infect Immun 73:1196\u20131203","journal-title":"Infect Immun"},{"key":"68_CR79","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1016\/j.vaccine.2006.05.097","volume":"24","author":"VK Sambandamurthy","year":"2006","unstructured":"Sambandamurthy VK, Derrick SC, Hsu T et al (2006) Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24:6309\u20136320","journal-title":"Vaccine"},{"key":"68_CR80","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/IAI.72.5.3031-3037.2004","volume":"72","author":"SL Sampson","year":"2004","unstructured":"Sampson SL, Dascher CC, Sambandamurthy VK et al (2004) Protection elicited by a double leucine and pantothenate auxotroph of Mycobacterium tuberculosis in guinea pigs. Infect Immun 72:3031\u20133037","journal-title":"Infect Immun"},{"key":"68_CR81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/hv.2.2.2620","volume":"2","author":"JA Schalk","year":"2006","unstructured":"Schalk JA, Mooi FR, Berbers GA et al (2006) Preclinical and clinical safety studies on DNA vaccines. Hum Vaccin 2:45\u201353","journal-title":"Hum Vaccin"},{"key":"68_CR82","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1099\/jmm.0.46983-0","volume":"56","author":"RH Senaratne","year":"2007","unstructured":"Senaratne RH, Mougous JD, Reader JR et al (2007) Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. J Med Microbiol 56:454\u2013458","journal-title":"J Med Microbiol"},{"key":"68_CR83","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/421472","volume":"190","author":"DR Sherman","year":"2004","unstructured":"Sherman DR, Guinn KM, Hickey MJ et al (2004) Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Gu\u00e9rin in long-term murine infection. J Infect Dis 190:123\u2013126","journal-title":"J Infect Dis"},{"key":"68_CR84","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-3083.2008.02207.x","volume":"69","author":"C Shi","year":"2009","unstructured":"Shi C, Yuan S, Zhang H et al (2009) Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by HSP65 and hIL-2 fusion protein in mice. Scand J Immunol 69:140\u2013149","journal-title":"Scand J Immunol"},{"key":"68_CR85","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","volume":"172","author":"YA Skeiky","year":"2004","unstructured":"Skeiky YA, Alderson MR, Ovendale PJ et al (2004) Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immunol 172:7618\u20137628","journal-title":"J Immunol"},{"key":"68_CR86","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/IAI.68.1.214-220.2000","volume":"68","author":"RL Skjot","year":"2000","unstructured":"Skjot RL, Oettinger T, Rosenkrands I et al (2000) Comparative evaluation of low molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immuno-dominant T cell antigens. Infect Immun 68:214\u2013220","journal-title":"Infect Immun"},{"key":"68_CR87","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/IAI.70.10.5446-5453.2002","volume":"70","author":"RL Skjot","year":"2002","unstructured":"Skjot RL, Brock I, Arend SM et al (2002) Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family. Infect Immun 70:5446\u20135463","journal-title":"Infect Immun"},{"key":"68_CR88","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1128\/IAI.69.2.1442-1150.2001","volume":"69","author":"DA Smith","year":"2001","unstructured":"Smith DA, Parish T, Stroker NG et al (2001) Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect Immun 69:1142\u20131150","journal-title":"Infect Immun"},{"key":"68_CR89","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4049\/jimmunol.162.2.1113","volume":"162","author":"A Tanghe","year":"1999","unstructured":"Tanghe A, Lefevre P, Denis O et al (1999) Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol 162:1113\u20131119","journal-title":"J Immunol"},{"key":"68_CR90","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1128\/IAI.68.7.3854-3860.2000","volume":"68","author":"A Tanghe","year":"2000","unstructured":"Tanghe A, Denis O, Lambrecht B et al (2000) Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection, but not by epidermal gene gun bombardment. Infect Immun 68:3854\u20133860","journal-title":"Infect Immun"},{"key":"68_CR91","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/IAI.71.4.2192-2198.2003","volume":"71","author":"JL Taylor","year":"2003","unstructured":"Taylor JL, Turner OC, Basaraba RJ et al (2003) Pulmonary necrosis resulting from DNA vaccination against tuberculosis. Infect Immun 71:2192\u20132198","journal-title":"Infect Immun"},{"key":"68_CR92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/abbs\/36.4.269","volume":"36","author":"X Tian","year":"2004","unstructured":"Tian X, Cai H, Zhu YX (2004) Protection of mice with a divalent tuberculosis DNA vaccine encoding antigens Ag85B and MPT64. Acta Biochem Biophys Sin 36:269\u2013276","journal-title":"Acta Biochem Biophys Sin"},{"key":"68_CR93","first-page":"1410","volume":"85","author":"X Tian","year":"2005","unstructured":"Tian X, Cai H, Zhu YX (2005) Immunogenicity and protection of divalent DNA vaccine encoding antigens MPT83 and MPT64 of Mycobacterium tuberculosis. Zhonghua Yi Xue Za Zhi 85:1410\u20131413","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"68_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7883\/yoken.52.1","volume":"52","author":"T Tokunaga","year":"1999","unstructured":"Tokunaga T, Yamamoto T, Yamamoto S (1999) How BCG led to the discovery of immunostimulatory DNA. Jpn J Infect Dis 52:1\u201311","journal-title":"Jpn J Infect Dis"},{"key":"68_CR95","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","volume":"367","author":"BB Trunz","year":"2006","unstructured":"Trunz BB, Fine P, Dye C (2006) Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367:1173\u20131180","journal-title":"Lancet"},{"key":"68_CR96","unstructured":"Tsenova L, Skeiky YAW, Ellison E et al (2003) Anti-tuberculosis vaccine evaluation using a rabbit model. TB vaccines for the world. Montreal, Canada, September 17\u201319 (abstract)"},{"key":"68_CR97","first-page":"819","volume":"57","author":"Tuberculosis Prevention Trial","year":"1979","unstructured":"Tuberculosis Prevention Trial (1979) Trial of BCG vaccines in South India for tuberculosis: first report. Bulletin of the World Health Organization 57:819\u2013827","journal-title":"Bulletin of the World Health Organization"},{"key":"68_CR98","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0264-410X(96)00255-1","volume":"15","author":"JB Ulmer","year":"1997","unstructured":"Ulmer JB, Liu MA, Montogomery DL et al (1997) Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination. Vaccine 15:792\u2013794","journal-title":"Vaccine"},{"issue":"suppl 3","key":"68_CR99","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1086\/313880","volume":"30","author":"RD Waddell","year":"2000","unstructured":"Waddell RD, Chintu C, Lein AD et al (2000) Safety and immunogenicity of a five-dose series of inactivated Mycobacterium vaccae vaccination for the prevention of HIV-associated tuberculosis. Clin Infect Dis 30(suppl 3):S309\u2013S315","journal-title":"Clin Infect Dis"},{"key":"68_CR100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/adc.2006.098459","volume":"91","author":"V Walker","year":"2006","unstructured":"Walker V, Selby G, Wacogne I (2006) Does neonatal BCG vaccination protect against tuberculous meningitis? Arch Dis Child 91:789\u2013791","journal-title":"Arch Dis Child"},{"key":"68_CR101","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1600-0463.2008.01095.x","volume":"116","author":"LM Wang","year":"2008","unstructured":"Wang LM, Bai YL, Shi CH et al (2008) Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (HSP65) with human interleukin-2 against Mycobacterium tuberculosis in BALB\/c mice. APMIS 116:1071\u20131081","journal-title":"APMIS"},{"key":"68_CR102","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00430-008-0098-x","volume":"198","author":"JL Wang","year":"2009","unstructured":"Wang JL, Qie YQ, Zhu BD et al (2009) Evaluation of a recombinant BCG expressing antigen AG85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL\/c mice. Med Microbiol Immunol 198:5\u201311","journal-title":"Med Microbiol Immunol"},{"key":"68_CR103","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1365-2249.2000.01100.x","volume":"119","author":"A Wangoo","year":"2000","unstructured":"Wangoo A, Brown IN, Marshall BG et al (2000) Bacille Calmette-Guerin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma). Clin Exp Immunol 119:92\u201398","journal-title":"Clin Exp Immunol"},{"key":"68_CR104","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","volume":"69","author":"A Weinrich Olsen","year":"2001","unstructured":"Weinrich Olsen A, van Pinxteren LA, Meng Okkels L et al (2001) Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Infect Immun 69:2773\u20132778","journal-title":"Infect Immun"},{"key":"68_CR105","unstructured":"World Health Organization (2007) Global Tuberculosis Control, Surveillance, Planning, Financing"},{"key":"68_CR106","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/IAI.74.1.557-565.2006","volume":"74","author":"TM Wozniak","year":"2006","unstructured":"Wozniak TM, Ryan AA, Triccas JA et al (2006) Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect Immun 74:557\u2013565","journal-title":"Infect Immun"},{"key":"68_CR107","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1128\/IAI.00244-07","volume":"75","author":"B Wu","year":"2007","unstructured":"Wu B, Huang C, Garcia L et al (2007) Unique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin. Infect Immun 75:3658\u20133664","journal-title":"Infect Immun"},{"key":"68_CR108","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1016\/j.vaccine.2008.06.044","volume":"26","author":"J Xu","year":"2008","unstructured":"Xu J, Xu W, Chen X et al (2008) Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice. Vaccine 26:4519\u20134525","journal-title":"Vaccine"},{"key":"68_CR109","first-page":"1227","volume":"39","author":"D Yadav","year":"2001","unstructured":"Yadav D, Khuller GK (2001) Evaluation of immune responses directed against 30\u00a0kDa secretory proteins of Mycobacterium tuberculosis H37Ra complexed in different adjuvants. Indian J Exp Biol 39:1227\u20131234","journal-title":"Indian J Exp Biol"},{"key":"68_CR110","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.vaccine.2005.08.103","volume":"24","author":"S Yoshida","year":"2006","unstructured":"Yoshida S, Tanaka T, Kita Y et al (2006) DNA vaccine using hemagglutinating virus of Japan-liposome encapsulating combination encoding mycobacterial heat shock protein 65 and interleukin-12 confers protection against Mycobacterium tuberculosis by T cell activation. Vaccine 24:1191\u20131204","journal-title":"Vaccine"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-010-0068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-010-0068-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-010-0068-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-010-0068-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:47:00Z","timestamp":1704228420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-010-0068-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,7]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["68"],"URL":"https:\/\/doi.org\/10.1007\/s00005-010-0068-z","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,7]]},"assertion":[{"value":"14 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}